BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18981156)

  • 1. Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells.
    Kimura T; Mogi C; Tomura H; Kuwabara A; Im DS; Sato K; Kurose H; Murakami M; Okajima F
    J Immunol; 2008 Nov; 181(10):7332-40. PubMed ID: 18981156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells.
    Kimura T; Tomura H; Mogi C; Kuwabara A; Damirin A; Ishizuka T; Sekiguchi A; Ishiwara M; Im DS; Sato K; Murakami M; Okajima F
    J Biol Chem; 2006 Dec; 281(49):37457-67. PubMed ID: 17046831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.
    Ren K; Lu YJ; Mo ZC; -Liu X; Tang ZL; Jiang Y; Peng XS; Li L; Zhang QH; Yi GH
    J Physiol Biochem; 2017 May; 73(2):287-296. PubMed ID: 28181168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells.
    Pan B; Kong J; Jin J; Kong J; He Y; Dong S; Ji L; Liu D; He D; Kong L; Jin DK; Willard B; Pennathur S; Zheng L
    Biochim Biophys Acta; 2016 Jun; 1861(6):501-12. PubMed ID: 27012521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells.
    Kimura T; Tomura H; Sato K; Ito M; Matsuoka I; Im DS; Kuwabara A; Mogi C; Itoh H; Kurose H; Murakami M; Okajima F
    J Biol Chem; 2010 Feb; 285(7):4387-97. PubMed ID: 20018878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.
    Yuhanna IS; Zhu Y; Cox BE; Hahner LD; Osborne-Lawrence S; Lu P; Marcel YL; Anderson RG; Mendelsohn ME; Hobbs HH; Shaul PW
    Nat Med; 2001 Jul; 7(7):853-7. PubMed ID: 11433352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ligand-independent apoptotic pathway induced by scavenger receptor class B, type I and suppressed by endothelial nitric-oxide synthase and high density lipoprotein.
    Li XA; Guo L; Dressman JL; Asmis R; Smart EJ
    J Biol Chem; 2005 May; 280(19):19087-96. PubMed ID: 15749707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoA-I induces S1P release from endothelial cells through ABCA1 and SR-BI in a positive feedback manner.
    Liu X; Ren K; Suo R; Xiong SL; Zhang QH; Mo ZC; Tang ZL; Jiang Y; Peng XS; Yi GH
    J Physiol Biochem; 2016 Dec; 72(4):657-667. PubMed ID: 27377933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.
    Rajesh M; Mukhopadhyay P; Bátkai S; Haskó G; Liaudet L; Huffman JW; Csiszar A; Ungvari Z; Mackie K; Chatterjee S; Pacher P
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2210-8. PubMed ID: 17660390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization.
    Lee MH; Appleton KM; El-Shewy HM; Sorci-Thomas MG; Thomas MJ; Lopes-Virella MF; Luttrell LM; Hammad SM; Klein RL
    J Lipid Res; 2017 Feb; 58(2):325-338. PubMed ID: 27881715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I.
    Okajima F; Sato K; Kimura T
    Endocr J; 2009; 56(3):317-34. PubMed ID: 18753704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of simvastatin on the TNF-alpha- and angiotensin II-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ROS generation.
    Park SY; Lee JS; Ko YJ; Kim AR; Choi MK; Kwak MK; Choi HG; Yong CS; Kim JA
    Arch Pharm Res; 2008 Feb; 31(2):195-204. PubMed ID: 18365690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.
    Keul P; Polzin A; Kaiser K; Gräler M; Dannenberg L; Daum G; Heusch G; Levkau B
    FASEB J; 2019 Jan; 33(1):1482-1495. PubMed ID: 30130432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.
    Zhu W; Saddar S; Seetharam D; Chambliss KL; Longoria C; Silver DL; Yuhanna IS; Shaul PW; Mineo C
    Circ Res; 2008 Feb; 102(4):480-7. PubMed ID: 18174467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
    González-Díez M; Rodríguez C; Badimon L; Martínez-González J
    Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma-derived and synthetic high-density lipoprotein inhibit tissue factor in endothelial cells and monocytes.
    Ossoli A; Remaley AT; Vaisman B; Calabresi L; Gomaraschi M
    Biochem J; 2016 Jan; 473(2):211-9. PubMed ID: 26556891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate (S1P) inhibits monocyte-endothelial cell interaction by regulating of RhoA activity.
    Tani M; Kawakami A; Nagai M; Shimokado K; Kondo K; Yoshida M
    FEBS Lett; 2007 Oct; 581(24):4621-6. PubMed ID: 17825823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation.
    Zapolska-Downar D; Naruszewicz M
    J Physiol Pharmacol; 2009 Jun; 60(2):123-31. PubMed ID: 19617655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
    Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.